In a study conducted in 2019, B7-H3 overexpression was found in patients with advanced-stage ovarian cancer, thus indicating that B7-H3 is wholly associated with the tumor stage in ovarian cancer. The gene discussed is CD276; the disease is ovarian carcinoma.